Text Size
1865 studies found for:    Mexico

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Active, not recruiting Open-label Follow up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam in Subjects Aged 16 Years or Older Suffering From Epilepsy.
Condition: Epilepsy
Intervention: Drug: Brivaracetam
2 Completed
Has Results 		Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease
Condition: Hyperlipidemia
Interventions: Drug: Rosuvastatin;   Drug: Atorvastatin
3 Completed
Has Results 		Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Stroke
Interventions: Drug: warfarin;   Drug: Dabigatran dose 1;   Drug: Dabigatran dose 2
4 Terminated (ARTEMIS-IPF)Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: ambrisentan or sugar pill
5 Recruiting Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection
Condition: Intraabdominal Infections
Interventions: Drug: Moxifloxacin (Avelox, BAY12-8039);   Drug: Ertapenem, Amoxicillin/clavulanate
6 Not yet recruiting MAESTRO-OL: Macitentan in Eisenmenger Syndrome To Restore Exercise Capacity (Open-Label)
Condition: Eisenmenger Syndrome
Intervention: Drug: Macitentan 10 mg tablet, once daily.
7 Completed
Has Results 		Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
Conditions: Breast Cancer;   Metastases
Interventions: Drug: Ixabepilone + Capecitabine;   Drug: Capecitabine
8 Completed Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study
Condition: NSCLC
Intervention: Drug: Gefitinib
9 Completed A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: GLP-1;   Drug: Placebo
10 Active, not recruiting Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Condition: Venous Thrombosis
Interventions: Drug: Enoxaparin;   Drug: warfarin;   Drug: Placebo for apixaban;   Drug: Placebo for enoxaparin;   Drug: Placebo for warfarin;   Drug: apixaban
11 Completed
Has Results 		Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
12 Recruiting GLORIA-AF Registry Program - Second and Third Phases
Conditions: Stroke;   Atrial Fibrillation
Intervention:
13 Recruiting MAESTRO (Macitentan in Eisenmenger Syndrome To Restore Exercise Capacity)
Condition: Eisenmenger Syndrome
Interventions: Drug: Macitentan 10 mg, oral tablet, to be taken once daily.;   Drug: Matching placebo oral tablet, to be taken once daily.
14 Completed A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: Certolizumab Pegol
15 Completed A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Biological: MVA-BN® (IMVAMUNE);   Biological: IMVAMUNE
16 Active, not recruiting PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
Condition: Non Hodgkin Lymphoma
Interventions: Drug: enzastaurin;   Drug: placebo
17 Completed Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
Conditions: Venous Thrombosis;   Pulmonary Embolism
Interventions: Drug: Apixaban;   Drug: Enoxaparin
18 Completed
Has Results 		Phase IIIB Switching From Intravenous to Subcutaneous Study
Condition: Arthritis, Rheumatoid
Intervention: Drug: Abatacept
19 Recruiting Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
Condition: Myelodysplastic Syndromes
Interventions: Drug: Deferasirox;   Drug: Deferasirox placebo
20 Active, not recruiting A Rheumatoid Arthritis Study in Patients on a Background Treatment of Methotrexate
Condition: Rheumatoid Arthritis
Interventions: Drug: LY2127399;   Drug: Placebo every 2 weeks;   Drug: Placebo every 4 weeks
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years